Crossmark

Cutting Through the “Gray Area”: An Analysis of the IBC Regulatory Oversight of Applications of CRISPR Technology in Clinical Research

Published Online: 2021-05-18

Published Print: 2021-09

Authors

Weiss, Westley F. https://orcid.org/0000-0002-2749-1423
License Information

Text and Data Mining valid from 2021-05-18

Version of Record valid from 2021-05-18
More Information

Article History

Received: 8 September 2020

Accepted: 9 April 2021

First Online: 18 May 2021

Declaration

:

: The author declares that there are no conflicts of interest.

Document is current